Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05004454 · ClinicalTrials.gov registry record · NA
Effect of Bacillus Subtilis BS50 Supplementation on Gastrointestinal Symptoms in Healthy Adults
A NA study, sponsored by BIO-CAT Microbials.
- Completed
- Registry status
- NA
- Development phase
- 76
- Enrollment target
NCT05004454 is a NA study that has completed, run by BIO-CAT Microbials. The registered enrollment target is 76 participants.
The verdict
NCT05004454, a NA study, has completed, sponsored by BIO-CAT Microbials.
- COMPLETED
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
Study Summary
The primary objective of this study is to investigate the effect of a novel Bacillus subtilis spore preparation on abdominal bloating, flatulence, and burping in healthy adults.
Interventions
- DIETARY_SUPPLEMENT Maltodextrin
- DIETARY_SUPPLEMENT Bacillus subtilis BS50 spore preparation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2021-07-19 |
| Est. Completion | 2021-11-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05004454
The ClinicalTrials.gov registry entry for NCT05004454 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BIO-CAT Microbials, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Maltodextrin is the first listed.
NCT05004454 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05004454 about?
NCT05004454 is a clinical study titled "Effect of Bacillus Subtilis BS50 Supplementation on Gastrointestinal Symptoms in Healthy Adults". The primary objective of this study is to investigate the effect of a novel Bacillus subtilis spore preparation on abdominal bloating, flatulence, and burping in healthy adults.
What is the current status of trial NCT05004454?
This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 2021-07-19. Estimated completion is 2021-11-08.
What interventions are being tested in trial NCT05004454?
The interventions under investigation include: Maltodextrin (DIETARY_SUPPLEMENT), Bacillus subtilis BS50 spore preparation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05004454?
This trial is sponsored by BIO-CAT Microbials, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.